AR044131A1 - Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad - Google Patents

Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Info

Publication number
AR044131A1
AR044131A1 ARP040101464A ARP040101464A AR044131A1 AR 044131 A1 AR044131 A1 AR 044131A1 AR P040101464 A ARP040101464 A AR P040101464A AR P040101464 A ARP040101464 A AR P040101464A AR 044131 A1 AR044131 A1 AR 044131A1
Authority
AR
Argentina
Prior art keywords
modified
almidon
improvement
heat
humidity resistance
Prior art date
Application number
ARP040101464A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR044131A1 publication Critical patent/AR044131A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Dental Preparations (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Grain Derivatives (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una película consumible adaptada para adherirse y disolverse en la cavidad oral de un animal de sangre caliente incluyendo los seres humanos, que comprende un almidón modificado como por ejemplo almidón plegelatinizado, entre otros; un agente farmacéuticamente activo pextrometorfano, famotidina y ranitidina, entre otros, y, opcionalmente, al menos un polímero hidrosoluble. Procedimiento para liberar y potenciar la liberación de un agente farmacéuticamente activo a la cavidad oral de un animal de sangre caliente.
ARP040101464A 2003-05-02 2004-04-29 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad AR044131A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46733903P 2003-05-02 2003-05-02

Publications (1)

Publication Number Publication Date
AR044131A1 true AR044131A1 (es) 2005-08-24

Family

ID=33418443

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101464A AR044131A1 (es) 2003-05-02 2004-04-29 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Country Status (19)

Country Link
US (1) US20040247648A1 (es)
EP (1) EP1622595A1 (es)
JP (1) JP2006525308A (es)
CN (1) CN1784218A (es)
AR (1) AR044131A1 (es)
AU (1) AU2004233744A1 (es)
BR (1) BRPI0409463A (es)
CA (1) CA2523372A1 (es)
CL (1) CL2004000931A1 (es)
CO (1) CO5640073A2 (es)
GT (1) GT200400085A (es)
MX (1) MXPA05010422A (es)
PA (1) PA8601801A1 (es)
PE (1) PE20050175A1 (es)
RU (1) RU2005129309A (es)
TW (1) TW200503786A (es)
UY (1) UY28304A1 (es)
WO (1) WO2004096193A1 (es)
ZA (1) ZA200507205B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
DE102004002951A1 (de) * 2004-01-21 2005-08-11 Wella Ag Verfahren zur Herstellung haarfestigender Produkte in Folienform
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20070293580A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
US20070292481A1 (en) * 2006-06-16 2007-12-20 Hoffman Andrew J Packaging of Food Products with Pullulan Films
US20080152761A1 (en) * 2006-12-20 2008-06-26 Shiji Shen Packaging of Food Products with Pullulan Films
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
DE102006061287A1 (de) * 2006-12-22 2008-06-26 Lts Lohmann Therapie-Systeme Ag Eßbare folienförmige Zubereitung mit Cola-Geschmack
US20090011115A1 (en) * 2007-03-13 2009-01-08 Foss Carter D Edible Pullulan Films Containing Flavoring
US20080274252A1 (en) * 2007-04-12 2008-11-06 Hoffman Andrew J Pullulan film containing sweetener
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20100266669A1 (en) * 2007-12-11 2010-10-21 Novartis Ag Multi-zone films
US20110114657A1 (en) * 2009-11-13 2011-05-19 Nygaard Leann M Beverage container holder and edible film package assembly
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
EP3095441B1 (en) * 2010-10-08 2020-12-02 R.P. Scherer Technologies, LLC Oral vaccine fast-dissolving dosage form using starch
US20130052234A1 (en) * 2011-08-25 2013-02-28 Purebrands LLC Edible strips
CN102836144A (zh) * 2012-09-28 2012-12-26 天津市聚星康华医药科技有限公司 一种去氧肾上腺素口腔速溶膜及其制备方法
BR112016002205A2 (pt) 2013-07-31 2017-08-01 Bluepharma Ind Farmaceutica S A filmes orodispersíveis
CN104530489B (zh) * 2015-02-05 2017-07-07 湖南尔康制药股份有限公司 一种速溶于水的淀粉成膜组合物
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
CN104983732B (zh) * 2015-05-28 2018-05-04 华润三九医药股份有限公司 一种布洛肾素那敏片及其制备方法
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
EP3416619A2 (en) * 2016-02-18 2018-12-26 Immune Therapeutics, Inc. Method for inducing a sustained immune response
DK3678648T3 (da) 2017-09-08 2023-09-11 Insignis Therapeutics Inc Fremgangsmåder til anvendelse af dipivefrin
US11213484B2 (en) 2019-03-01 2022-01-04 Insignis Therapeutics, Inc. Dipivefrin orally disintegrating tablet formulations
KR102221453B1 (ko) * 2019-07-19 2021-03-02 한국프라임제약주식회사 저분자 콜라겐 펩타이드 및 천연추출복합물을 포함하는 구강점막부착형 필름 조성물 및 이를 이용하여 제조된 구강점막부착형 필름
CN117653610B (zh) * 2023-09-28 2024-07-05 海南卓科制药有限公司 一种硝酸甘油片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US4197289A (en) * 1975-12-15 1980-04-08 Hoffmann-La Roche Inc. Novel dosage forms
US4562020A (en) * 1982-12-11 1985-12-31 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing self-supporting glucan film
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5354551A (en) * 1989-10-14 1994-10-11 Desitin Arzneimittel Gmbh Oral and dental hygiene preparation
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
JP3232488B2 (ja) * 1992-08-20 2001-11-26 株式会社林原生物化学研究所 プルラン高含有物とその製造方法並びに用途
US5411945A (en) * 1992-08-29 1995-05-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pullulan binder and its uses
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US20030118653A1 (en) * 2001-07-06 2003-06-26 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
EP1458367B2 (en) * 2001-10-12 2021-01-27 Aquestive Therapeutics, Inc. Uniform films for rapidly dissolving dosage form incorporating taste-masking compositions
ATE536869T1 (de) * 2001-10-12 2011-12-15 Monosolrx Llc Auf glucan-film basierte wirkstoffverabreichungssysteme
JP2003213038A (ja) * 2001-11-16 2003-07-30 Natl Starch & Chem Investment Holding Corp デンプンを含有するフィルム
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch

Also Published As

Publication number Publication date
WO2004096193A1 (en) 2004-11-11
BRPI0409463A (pt) 2006-05-02
PE20050175A1 (es) 2005-03-21
AU2004233744A1 (en) 2004-11-11
PA8601801A1 (es) 2004-11-26
EP1622595A1 (en) 2006-02-08
MXPA05010422A (es) 2005-11-04
UY28304A1 (es) 2004-11-30
TW200503786A (en) 2005-02-01
GT200400085A (es) 2005-03-03
CO5640073A2 (es) 2006-05-31
CN1784218A (zh) 2006-06-07
CA2523372A1 (en) 2004-11-11
ZA200507205B (en) 2006-11-29
JP2006525308A (ja) 2006-11-09
CL2004000931A1 (es) 2005-01-07
RU2005129309A (ru) 2006-05-10
US20040247648A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
UY28304A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
UY28285A1 (es) Péliculas consumibles por vía oral que se disuelven rápidamente, que contienen un edulcorante
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
UY28431A1 (es) Peliculas que se disuelven por via oral
AR053731A1 (es) Aromatizacion de gomas de mascar que contienen farmacos
UY25728A1 (es) Peliculas consumibles oralmente que se disuelve rapidamente
EP2493457A4 (en) FAST SOLUBLE SOLID DOSAGE FORM
AR058175A1 (es) Composiciones farmaceuticas solidas que contienen pregabalina
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
PT1883452E (pt) Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
CR9839A (es) Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica
ES2582871T3 (es) Composición terapéutica aromatizada basada en arcilla
CL2007003451A1 (es) Composicion farmaceutica solida oral que comprende un principio activo y polivinilpirrolidona (pvp) entre 1,0-25%, cpaa entre 0,5-10%, el principio activo consiste en una sal hidrosoluble de metal alcalino, de metal alcalino-terreo, una sal de mezcla
ECSP003685A (es) Formulaciones orales de liberacion controlada
DOP2004000897A (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejorade la resistencia al calor y a la humedad
AR065703A1 (es) Uso de una micro - emulsion acuosa para la preparacion de una formulacion para el tratamiento de enfermedades adiposas y dicha micro - emulsion
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
AR053144A1 (es) Composicion farmaceutica solida que comprende telitromicina
PE20070464A1 (es) Forma farmaceutica con liberacion sostenida independiente del ph de un ingrediente activo, para ingredientes activos que tienen una solubilidad que depende en gran medida del ph
AR048432A1 (es) Composiciones diureticas de liberacion prolongada
AR046205A1 (es) Formulacion farmaceutica de licofelona
AR048355A1 (es) Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen
AR040561A1 (es) Sistema de administracion espaciada de farmacos

Legal Events

Date Code Title Description
FB Suspension of granting procedure